Severe Combined Immunodeficiency (SCID)
Gene or Region: DNAPK
Reference Variant: TCTCA
Mutant Variant: -
Affected Breeds: Arabian
Research Confidence: High - Findings reproduced in multiple studies
Explanation of Results: scid/scid = homozygous for Severe Combined Immunodeficiency, trait expressed scid/n = heterozygous for Severe Combined Immunodeficiency, carrier n/n = no variant detected
General Information
Severe combined immunodeficiency disease is a condition in which the foal has essentially no immune system, due to a complete absence of certain types of immune cells, specifically B and T lymphocytes. Affected foals are unable to mount an effective immune response after infection and are unable to recover from infections that unaffected foals would easily resist. The disease is universally fatal in horses, usually within 4-6 months of life. It is a recessive trait, meaning that it requires two mutant alleles to manifest; animals carrying just one copy of the mutant allele are completely healthy and are “carriers”, meaning that they can pass the mutation to their offspring. If two carrier horses mate, there is a 25% chance that the foal will have SCID. It has only been detected in horses of Arabian descent, and studies have determined that ~8% of Arabian horses are carriers of the SCID allele.
The particular mutation assessed is a five-nucleotide deletion within the DNAPK gene, leading to a mutant form of the DNA-PK protein that is non-functional. DNA-PK is involved in a process called V(D)J recombination, which leads the development of mature B and T lymphocytes. All known cases of horse SCID arise from this mutation.
Publications
Ding et al., DNA-PKcs mutations in dogs and horses: allele frequency and association with neoplasia.” (2002) Gene 283: 263-9. PMID: 11867233
Bernoco, D and Bailey, E, “Frequency of the SCID gene among Arabian horses in the USA.” (1998) Animal Genetics 29: 41-42. PMID: 9682449
Shin et al., “A Kinase-Negative Mutation of DNA-PKcs in Equine SCID Results in Defective Coding and Signal Joint Formation.” (1997) Journal of Immunology 158: 3565-9. PMID: 9103416
More Horse Health
Equine Recurrent Uveitis Risk and Severity
Equine Recurrent Uveitis (ERU) is the most common cause of blindness in horses, affecting about 3-15% of the horse population worldwide. Characterized by episodes of inflammation of the middle layer of the eye, Equine Recurrent Uveitis in horses leads to the development of cataracts, glaucoma and eventually complete loss of vision.
Foal Immunodeficiency Syndrome
Foal immunodeficiency syndrome (FIS) is a failure in the development of the adaptive immune system. At 3-6 weeks of age, once the maternal antibodies begin to degrade, foals exhibit signs of anemia, diarrhea, and pneumonia. As these foals fail to respond to treatment for infections, they are humanely euthanized at a young age.
Glanzmann Thrombasthenia
Glanzmann Thrombasthenia (GT) is a blood platelet function disorder, resulting from a reduction in the platelet fibrinogen receptor protein. Clinical signs can be characterized by bleeding on the skin or from the mouth/nostril/gastrointestinal mucosas, and may include skin rashes with blood spots under the skin, nasal bleeding, gastrointestinal and gingival bleedings.
Glycogen Branching Enzyme Deficiency
Glycogen Branching Enzyme Deficiency (GBED) is a lethal recessive disorder characterized by seizures, muscle weakness, respiratory failure, and death. Many affected foals do not make it full term and are aborted or stillborn. Carriers (gbed/n) have no known issues.